Immucell Corp /de/ ICCC US Equity
$9.94
-0.08 (-0.80%)
USD · as of 2026-08-28 · marketstack
Immucell Corp /de/ (Nasdaq: ICCC), an SEC filer in In Vitro & In Vivo Diagnostic Substances, closed at $9.94, -0.8%, on 2026-08-28, with a market cap of $91M as of 2026-08-27, a return on equity of -3.8%, a net margin of -3.8% and 3-year sales growth of 14.2%. Institutional ownership, earnings history and filed financials are on the tabs below.
| Date | Event | What happened / filer | Source |
|---|---|---|---|
| 2026-08-13 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2026-07-09 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
Source: SEC EDGAR (public domain) · history starts 2026-07-09
Every row is a filed document, checked against its EDGAR index.